-- Aurora Cannabis (ACB.TO) is "significantly" expanding its global medical cannabis portfolio, with product launches rolling out across Canada, Europe and Australia, the company said on Tuesday.
The newly expanded lineup includes dried flower, pre-rolls and pastilles, and will be rolled out between now and June, a statement added.
"By expanding our offerings in key countries, we're responding to clear patient and prescriber demand with products that meet local regulatory standards, offer meaningful choice across formats, and can be supplied reliably at scale - all while reinforcing the level of quality and trust expected from us," said Lana Culley, who heads innovation and international operations at Aurora.
Aurora shares were last seen down US$0.08, to US$3.43 in U.S. pre-market trading.